A Jersey-based start-up has been granted the second only licence in the British Isles to cultivate pharmaceutical-grade cannabis for profit, more than two decades after the first permit was issued.
A seven-year-old with a rare form of epilepsy has made an “amazing” recovery after beginning a medicinal cannabis oil treatment, her family said.
Medicinal cannabis could offer patients significant relief from intractable epilepsy, but cost and access barriers remain, a review has found.
The U.S. House of Representatives on Wednesday passed a groundbreaking bill to reduce barriers and expand scientific research into medical cannabis, a move that could be critical to convincing Republican lawmakers to support broader marijuana reform.
Rodrigo Martín was told by oncologists in Costa Rica that the cancer in his head had metastasized and that he had six months to live.
The new regulation also orders insurance providers to cover cannabis products prescribed by doctors.
Britain is set to see the greatest cannabis medical market growth rate in Europe between 2020-2025.
After being used therapeutically for thousands of years, a historic vote at the United Nations today has now finally recognised the medicinal value of cannabis.
Medical cannabis, namely cannabis-based products for medicinal use in humans (CBPMs), has been moved from Schedule 1 to Schedule 2 under the Misuse of Drugs Regulation 20011 in November 2018 following a very effective publicity campaign about two children with severe epilepsy.
In recent years, a number of cannabis-derived medicines, including both synthetic, and phytocannabinoids have been investigated for their potential in treating symptoms associated with Multiple Sclerosis (MS).